Clinical Trials Directory

Trials / Completed

CompletedNCT01759355

Hybrid PET/MR in the Therapy of Cervical Cancer

Hybrid PET/MR in the Therapy of Cervical Cancer: A Pilot Study

Status
Completed
Phase
Study type
Observational
Enrollment
18 (actual)
Sponsor
UNC Lineberger Comprehensive Cancer Center · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a two arm, single center feasibility study of 20 patients with non-metastatic cervical cancer managed with surgery and/or chemoradiation therapy at UNC Hospitals. Subjects will undergo PET/MRI scans before, during (chemoradiation group only), and after treatment.

Detailed description

The primary purpose of this study is to evaluate the feasibility of obtaining complete and interpretable hybrid PET/MR images for patients diagnosed with cervical cancer.

Conditions

Interventions

TypeNameDescription
PROCEDUREFDG PET/MRParticipants will undergo a FDG, gadolinium enhanced PET/MR scan.

Timeline

Start date
2012-10-01
Primary completion
2020-05-28
Completion
2020-05-28
First posted
2013-01-03
Last updated
2021-12-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01759355. Inclusion in this directory is not an endorsement.

Hybrid PET/MR in the Therapy of Cervical Cancer (NCT01759355) · Clinical Trials Directory